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The aim of this study was to evaluate the effect of a moxifloxacin-loaded organic-
inorganic sol-gel with different antibiotic concentration in the in vitro biofilm development
and treatment against Staphylococcus aureus, S. epidermidis, and Escherichia coli,
cytotoxicity and cell proliferation of MC3T3-E1 osteoblasts; and its efficacy in preventing
the prosthetic joint infection (PJI) caused by clinical strains of S. aureus and E. coli
using an in vivo murine model. Three bacterial strains, S. epidermidis ATCC 35984,
S. aureus 15981, and, E. coli ATCC 25922, were used for microbiological studies.
Biofilm formation was induced using tryptic-soy supplemented with glucose for 24 h,
and then, adhered and planktonic bacteria were estimated using drop plate method
and absorbance, respectively. A 24-h-mature biofilm of each species growth in a 96-
well plate was treated for 24 h using a MBECTM biofilm Incubator lid with pegs
coated with the different types of sol-gel, after incubation, biofilm viability was estimated
using alamrBlue. MC3T3-E1 cellular cytotoxicity and proliferation were evaluated using
CytoTox 96 Non-Radioactive Cytotoxicity Assay and alamarBlue, respectively. The
microbiological studies showed that sol-gel coatings inhibited the biofilm development
and treated to a mature biofilm of three evaluated bacterial species. The cell studies
showed that the sol-gel both with and without moxifloxacin were non-cytotoxic and that
cell proliferation was inversely proportional to the antibiotic concentration containing by
sol-gel. In the in vivo study, mice weight increased over time, except in the E. coli-
infected group without coating. The most frequent symptoms associated with infection
were limping and piloerection; these symptoms were more frequent in infected groups
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with non-coated implants than infected groups with coated implants. The response
of moxifloxacin-loaded sol-gel to infection was either total or completely absent.
No differences in bone mineral density were observed between groups with coated
and non-coated implants and macrophage presence lightly increased in the bone
grown directly in contact with the antibiotic-loaded sol-gel. In conclusion, moxifloxacin-
loaded sol-gel coating is capable of preventing PJI caused by both Gram-positive and
Gram-negative species.
Keywords: sol-gel, moxifloxacin, prosthetic joint infection, Staphylococcus epidermidis, Staphylococcus aureus,
Escherichia coli
INTRODUCTION
Prosthetic joint infection (PJI) occurs rarely (1–2% of all
cases), though its effects are often devastating due to the
high associated morbidity and substantial costs of this kind
of surgical complication (Tande and Patel, 2014). Additionally,
the economic burden of PJI is expected to rise in the
coming years with the increase in the life expectancy and
number of patients undergoing arthroplasty replacements
(Anagnostakos et al., 2009).
Gram-positive cocci are the most frequent microorganisms
isolated from PJIs, representing up to 77% of all PJIs; of these, the
most common species are Staphylococcus aureus and coagulase-
negative staphylococci (Benito et al., 2016). However, Gram-
negative bacilli can be isolated from 27–45% of all infections
(Cobo et al., 2011; Benito et al., 2016) and the most commonly
isolated species belong to the Enterobacteriaceae family, mainly
Escherichia coli, and several non-fermenting Gram-negative
bacilli. These organisms are gaining in importance given their
increasing incidence and antibiotic resistance (Rodriguez-Pardo
et al., 2014; Benito et al., 2016; Papadopoulos et al., 2019;
Pfang et al., 2019).
Systemic and prophylactic treatment of PJIs may be
ineffective, because antibiotics are unable to reach the prosthesis-
tissue interface due to necrotic and/or avascular tissue that
remains after surgery (Popat et al., 2007). Therefore, local
antibiotic therapy was proposed as an alternative and/or adjuvant
to systemic prophylaxis or treatment, preventing systemic
toxicity and favoring drug release directly within the implant site
(Zhao et al., 2009). Additionally, if the infection probability is
reduced, the osteointegration would be improved (Gristina, 1987;
Zhao et al., 2014; Martinez-Perez et al., 2017).
We recently demonstrated in an in vitro study
that an intermediate quantity of organophosphite,
[tris(trimethylsilyl) phosphite] in a sol-gel made of two silanes
(3-methacryloxypropyl trimethoxysilane and 2-tetramethyl
orthosilane) enhanced sol-gel adhesion on metallic surfaces and
increased cell proliferation (Garcia-Casas et al., 2019).
The aim of this study was to evaluate the effect of a
moxifloxacin-loaded organic-inorganic sol-gel in the in vitro
biofilm development and treatment, cytotoxicity and cell
proliferation. Finally, the efficacy of a moxifloxacin-loaded
organic-inorganic sol-gel in preventing PJI caused by S. aureus





Titanium substrates for microbiological studies were prepared
by a conventional powder metallurgy route applying a cold
uniaxial charge of 7.9 tn/cm2 followed by a sintering step at
1,250◦C for 120 min under high vacuum (10−5 mbar), as
described elsewhere by Bolzoni et al. (2017). The starting Ti
powders with a particle size below 75 µm were supplied by
AP&C Inc., (Canada). The metallic substrates were ground
with SiC paper of 1,000 grit and cleaned with ethanol in an
ultrasonic bath.
Sol-gel was prepared as described elsewhere
(El hadad et al., 2011) starting with a mixture of
γ-methacryloxypropyltrimethoxysilane 98% (Acros Organics,
Thermo Fisher Scientific, United States) and tetramethyl
orthosilane 98% (Acros Organics, Thermo Fisher Scientific,
United States) with a molar ratio of 1:2. Later, tris(trimethylsilyl)
phosphite 92% (Sigma-Aldrich, United States) was added
at a molar ratio of 1:52 with regard to the silanes (P2)
(Figure 1a). Moxifloxacin (Sigma-Aldrich, United States)
dissolved in water (Varanda et al., 2006) was added at two
concentration: a concentration of 25 mg (A25) (Figure 1b)
and a concentration of 50 mg per 20.3 mL of sol-gel (A50)
(Figure 1c). These concentrations have been intentionally
chosen because they represent 50% and maximum amount
of this antibiotic which sol-gel can contain without
compromising its stability, durability and adherence on
titanium substrates.
Antibiotic Release From Sol-Gel
Moxifloxacin release from sol-gels coating Ti samples was
evaluated by introducing in a polipropilene container containing
5 mL of phosphate bufferr saline (bioMérieux, France) previously
tempered at 37◦C. The antibiotic concentration was periodically
measured at 1, 3, 6, 12, 24, and 48 h. The fluorimetric
method previously described (Ocana et al., 2000) using
an excitation/emission wavelength of 287/465 nm and a
standard curve with known concentrations of antibiotic were
used to estimate the antibiotic concentration at each time
using 300 µL in a Polypropylene 96-well MicroWellTM Plate
(Thermo Fisher Scientific, United States). This experiment was
performed in triplicate.
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FIGURE 1 | Scanning electron microscopy micrograph of different sol-gel surfaces: P2 (a), A25 (b), and A50 (c).
Microbiological Study
The biofilm formation studies were carried out using three
bacterial strains: S. epidermidis ATCC 35984, S. aureus 15981
(Valle et al., 2003), and E. coli ATCC 25922. These species
represent the most common pathogens relate to this kind
of infection and serve as an example of strains susceptible
to this antibiotic. All the strains were kept frozen at −80◦C
until experiments were performed. Overnight culture of each
bacterium was grown in blood tryptic-soy agar (bioMérieux,
France) at 37◦C in 5% CO2. For each species 106 colony
forming units (CFU/ml) in tryptic soy broth with 1% glucose
as biofilm inductive growth medium were inoculated. After
incubation, the coatings were washed three times with 0.9%
NaCl sterile saline (SS) (B. Braun, Germany). Adhered CFU were
estimated by scraping the top disk surface with sterile wooden
sticks to corroborate the viability differences on each coating.
These wooden sticks with scrapped bacteria were sonicated
in a 50-mL FalconTM conical tube (Thermo Fisher Scientific,
United States) with 10 mL of SS, with an Ultrasons-H 3000840
low-power bath sonicator (J. P. Selecta, Spain) at 22◦C for 5 min
(Esteban et al., 2008). This sonicated SS was serially diluted
with SS and adhered CFU were estimated using the drop plate
method (Herigstad et al., 2001). Supernatant absorbance was
measured at 600 nm in eight replicates in a NuncTM 96-Well
Polypropylene MicroWellTM Plate for estimating planktonic
bacterial concentration. This experiment was performed by
triplicate for each strain.
Each type of sol-gel incubated with S. aureus 15981 were
then stained with the Live/Dead BactLight R© bacterial viability kit
(Thermo Fisher Scientific, Waltham, MA, United States)
to support visually the numerical results. Photographs
(40× magnification) were taken in a DM 2000 fluorescence
microscope (Leica Microsystems, Germany) for each sample.
This strain was the only one which was able to be stained and
photographed on sol-gels.
Mature biofilm was grown on black NuncTM F96 MicroWellTM
(Themo Fisher Scientific, United States) using 100 µL per well of
an inoculum of 106 CFU/mL of brain heart infusion (BHI) at 1%
(wt./vol.) (BD, United States) plus 0.03% of fetal bovine serum
(Sigma-Aldrich, United States), a culture medium that induces the
formation of bacterial biofilm (Perez-Jorge et al., 2017), incubated
at 37◦C and 5% CO2 for 24 h. After incubation, the mature
biofilm of each well was rinsed twice with 100 µL of SS and
200 µL of BHI at 1% (wt./vol.) with 0.03% of bovine fetal serum
(Sigma-Aldrich, United States) were added. The lid of the plate
was replaced by a MBECTM biofilm Incubator lid (Innovotech,
Canada) whose pegs were coated twice by dipping in wells filled
with 200 µL of each treatment (uncoated, P2, A25, and A50)
followed by incubation at 37◦C and 5% CO2 at 80 rpm for 48 h.
Viable bacteria concentration of the grown biofilm was estimated
by adding 10 µL of alamarBlue R© (BIO-RAD, United States) per
well and was incubated at 37◦C and 5% CO2 at 80 rpm for 1 h
(Pettit et al., 2005). The fluorescence was measured using an
excitation wavelength of 560 nm and an emission wavelength of
590 nm after incubation. The pegs of the uncoated material were
used as positive control. This experiment was performed in eight
wells per coating by triplicate for each strain.
Cell Study
MC3T3-E1 cells were seeded in a concentration of
10,000 cells/cm2 on 96-well plates with α-minimum essential
medium with 10% bovine fetal serum and 1% penicillin-
streptomycin (αMEM, Invitrogen, Thermo Fisher Scientific
Inc., United States) and were incubated at 37◦C and 5% CO2
overnight. After cell adherence, medium was replaced by αMEM
with 50 mg/mL ascorbic acid (Sigma-Aldrich, United States),
10 mM ß-glycerol-2-phosphate (Sigma-Aldrich, United States)
and different treatments: negative control, P2, A25, and A50
(n = 8 each) for promoting osteoblastic differentiation, and the
lid of the plate was replaced by a MBECTM biofilm Incubator
lid (Innovotech, Canada) whose pegs were coated by dipping in
wells filled with 200 µL of each treatment (negative control, P2,
A25, and A50) followed by incubation at 37◦C in 5% CO2 for
48 h. After incubation, cytotoxicity was tested by CytoTox 96 R©
Non-Radioactive Cytotoxicity Assay (Promega, United States).
Cell proliferation was determined by addition of alamarBlue R©
solution (BIO-RAD, United States) at 10% (v/v) to the cell culture
at 48 h of growth. Absorbance was measured with excitation and
emission wavelengths of 570 and 600 nm, respectively, in a Tecan
Infinite 200 Reader (Life Sciences, Switzerland).
In vivo Model
Sol-Gel Synthesis and Coating of Titanium Implants
The Ti-6Al-4V implants were prepared from 0.6-mm thick
Kirschner wires supplied by Depuy Synthes (Johnson & Johnson,
United States). Each wire was cut into implants measuring 1 cm
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in length. Next, these were chemically polished (CP) as described
previously (Arenas et al., 2013) to achieve a surface finish
more closely resembling that used in routine clinical practice
(Figures 2a,b). Finally, the Ti-6Al-4V implants for in vivo model
were coated by dipping in A50 and allowed to dry for at least 1 h
at 60◦C (CP+A50) (Figures 2c,d).
Animal Surgical Model and Monitoring
We used two clinical strains isolated in the Clinical Microbiology
department of the Fundación Jiménez Díaz University Hospital: a
strain of S. aureus from a 62-year-old man with an acute infection
of a hip prosthesis (Sa5) and a strain of E. coli from a 61-year-old
man with another acute infection, also in a hip prosthesis (Ec30).
This study uses strains obtained from PJIs. The Instituto
de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)
Research Commission did not require the study to be reviewed
or approved by an ethics committee because no clinical,
demographical, analytical nor any other data from the patients
were included, and bacterial strains do not need such approval
according to the present legislation.
Surgical intervention of the in vivo model was based on a
modified model previously described by Lovati et al. (2013).
The intervention consisted of placing the implant into the right
femur of SWISS RjOrl:SWISS (CD1 R©) mice (Janvier Labs, France)
through the knee using an aseptic surgical technique (Figure 3).
The main modifications consisted of: (1) replacing phosphate
buffer saline with saline, (2) using inhaled isoflurane (3.5%) as
the only anesthesia used, and finally, and (3) using chemically
polished, 1-cm-long implants made with Ti-6Al-4V instead of a
25-gauge needle, thereby simulating more realistic conditions.
Sixteen-week-old male mice with femoral implants were
distributed into six groups: one group with a CP implant without
infection (CP group, n = 8), a second group with a CP implant
with infection induced by Sa5 S. aureus (CP Sa5 group, n = 5),
a third group with a CP implant with infection induced by
Ec30 E. coli (CP Ec30 group, n = 5), a fourth group with a
CP implant coated with moxifloxacin-loaded sol-gel without
infection (CP+A50 group, n = 8), a fifth group with a CP implant
coated with moxifloxacin-loaded sol-gel with infection induced
by Sa5 (CP+A50 Sa5 group, n = 5), and a sixth group with a CP
implant coated with moxifloxacin-loaded sol-gel with infection
induced by Ec30 E. coli (CP+A50 Ec30 group, n = 5).
We assessed the pain-stress and weight of each animal every
48 h on weekdays to ensure physical status. Evaluation of pain-
stress consisted of the presence or absence of six behaviors
directly related to pain or stress in this species and for the surgical
procedure the animals had undergone: limping, piloerection, lack
of grooming, wound presence, passivity, and aggressiveness. In
FIGURE 2 | Scanning electron microscopy micrograph of CP (a,b) and CP+A50 surfaces (c,d) at 60 (a,c) and 2,000 (b,d) magnifications.
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FIGURE 3 | Fluoroscopy of a mouse with an implant placed in the femur in lateral (a) and dorsoventral (b) position.
cases of sustained weight loss over time, the most appropriate
refinement measures were taken to encourage the animal to
eat. For this, they were offered an additional mixture of grains
and vegetables (Vitakraft, Bremen, Deutschland). At 15 days
postsurgically, a urine sample was taken from all infected animals,
and bacteria presence was evaluated qualitatively.
Five weeks after surgery, the animals were euthanized using
hypercapnia. The entire femur of each animal was then recovered
through sterile preparation of the knee, including surgical
field isolation.
Microbiological Study
The biofilm formation ability of the different clinical strains
was evaluated according to a widely accepted published protocol
(Stepanovic et al., 2007). The strains were transferred from
stock culture into blood tryptic-soy agar and incubated at 37◦C
overnight under aerobic conditions. The next day, colonies were
suspended in TSB until a turbidity comparable to 0.5 MacFarland
scale (∼108 CFU/mL) was reached. This suspension was diluted
1:100 in TSB+1% glucose to reach a bacterial concentration of
approximately 106 CFU/mL. Then, 200 µL from the diluted
suspension was aliquoted into 96-well untreated microtiter plate
and incubated at 37◦C and 5% CO2 for 24 h under static aerobic
conditions. The next day, the wells were aspirated, and each
well was washed three times with 200 µL SS. After washing, the
remaining attached bacteria were fixed with 200 µL of methanol,
and incubated at room temperature for 20 min. The methanol
was discarded and plates were left to dry in at 60◦C. Finally,
the biofilm formed was stained with 200 µL of 2% crystal violet
for Sa5 and of 1% safranin for Ec30 for 15 min. Plates were
washed two times with 250 µL of sterile distilled water, and dye
bound to the cells was eluted with 250 µL of absolute ethanol.
The absorbance was measured at 570 nm for crystal violet and
at 492 nm for safranin using a microplate reader. Experiments
were performed in eight wells and repeated three times. The cut-
off value (optical density control, ODC) was defined as three
standard deviations above the mean OD of the negative control.
The strains were classified according to its optical density (OD)
per well within of the following categories: non-biofilm former
(OD ≤ ODC), weak biofilm former (ODC < OD < 2 × ODC),
moderate biofilm former (2 × ODC < OD < 4 × ODC) and
strong biofilm former (OD> 4× ODC).
The urine samples were seeded in CHROMID R© CPS R© Elite
(bioMérieux, France) to diagnose possible bacteriuria.
FIGURE 4 | Calibration curve resulting from known concentrations of moxifloxacin (MOX) and their fluorescence intensity (FI) (A); and amount of moxifloxacin
released from A25 (blue) and A50 (red) over time (B).
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Using a hammer, each femur was divided into two samples on
a sterile surface: (1) bone and adnexa, and (2) implant.
The bone was immersed in 2 mL of SS and sonicated using
an sonicator at 22◦C for 5 min (Esteban et al., 2008). The
resulting sonicate was diluted in a 10-fold dilution bank and
seeded on blood-chocolate agar (bioMérieux, France) using the
plaque extension method, which consists of seeding 100 µL/plate
of each dilution. The concentration of bacteria was estimated as
CFU/g of bone and adnexa.
The implant was sonicated in 2 mL of saline for 5 min
to release the adhered biofilm bacteria and estimated their
concentration, measured as CFU/cm2 of implant. All plates were
checked at 24 and 48 h.
Microcomputed Tomography
Three bone samples from each non-infected control group
included in the aforementioned model were fixed in 10%
formaldehyde for 48 h at 4◦C. After fixation, they were
dehydrated in 96% ethanol for 48 h, changing the ethanol
every 24 h, and in 100% ethanol for 48 h, changing the
ethanol every 24 h.
Three-dimensional microcomputed tomography was
performed with a CompaCT scanner (Sedecal, Spain). Data were
acquired with 720 projections by 360-degree scan, having an
integration time of 100 ms with three frames, photon energy of
50 KeV, and a current of 100 µA. The duration of imaging was
20 min per scan. Three-dimensional renderings of the hind paws
were generated using original volumetric images reconstructed
with MicroView software (GE Healthcare). Bone mass (BM,
mg), bone volume (BM, cm3), and bone mineral density
(BMD = BM/BV, mg/cm3) were quantified from MicroCT scans
using GE MicroView software 2.2.
Histological Studies
Three femurs of CP group and CP+A50 group were fixed in
4% paraformaldehyde for 48 h, decalcified in 10% EDTA for
4 weeks, paraffin-infiltrated, and stained with hematoxylin-eosin.
Implants were removed and transversal sections in the knee
condyles (5 µm) were done.
Tartrate-resistant acid phosphatase (TRAP) staining was
carried out in paraffin sections with a homemade TRAP
buffer (0.1 M acetate buffer, 0.3 M Sodium Tartrate 10 mg/ml
Naphtol AS-MX phosphate, 0.1% Triton X-100, 0.3 mg/ml
Fast Red Violet LB (Sigma-Aldrich, United States). After
deparaffinization and acetate buffer washing processes, samples
were incubated in TRAP buffer for 30 min and counterstained
with Fast Green.
Immunohistochemistry analysis was carried out as previously
described (Mediero et al., 2012). Briefly, sections were incubated
with proteinase K Solution (20 µg/mL in TE Buffer, pH
8.0) for 15 min in water bath at 37◦C for antigen retrieval
after deparaffinization and re-hydratation. Blocking of non-
specific binding was performed with PBS 3% BSA and 0.1%
Triton X-100 for 1 h, and primary antibodies anti-cathepsin K
(1:25), CD68 (1:200) and alkaline phosphatase (ALP) 1:200 (all
antibodies from Santa Cruz Biochenology, United States) were
incubated overnight at 4◦C in a humidifying chamber. Secondary
antibodies goat anti-rabbit-FITC (1:200), goat anti-mouse-
FITC (1:200) (Invitrogen, Life Technologies, United States)
were incubated for 1 h in the dark. Slides were mounted
FIGURE 5 | Bacterial biofilm concentration per area unit (CFU/cm2) and planktonic bacterial concentration (ABS) of S. epidermidis ATCC 35984 (A,D), S. aureus
15981 (B,E), and E. coli ATCC 25922 (C,F) on different types of coatings: P2, A25 and A50. ∗p-value < 0.05 for Wilcoxon test.
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FIGURE 6 | Staphylococcus aureus biofilm grown on each sol-gel and
stained using Live/Dead Bactlight to 40× magnification. Green bacteria are
viable and red ones are dead.
with Fluoroshield with DAPI mounting media (Sigma-Aldrich,
United States). Images were taken with the iScan Coreo Au
scanner (Ventana Medical Systems, Roche diagnostics, Spain)
and visualized with Image Viewer v.3.1 software (Ventana
Medical Systems, Roche diagnostics, Spain). Images were taken
at 4× or 10×magnifications.
Statistical Analysis
Statistical analyses were performed using Stata Statistical
Software, Release 11 (StataCorp, United States). Data were
evaluated using a one-sided Wilcoxon non-parametric test
to compare two groups. Statistical significance was set at
p-values ≤ 0.05. Body weight was evaluated over time using
a linear regression model. Microbiological, cellular results and
weight values are represented as median and interquartile range.
Other behavioral variables are represented as relative frequencies
at each time point.
RESULTS
In vitro Studies
Antibiotic Release From Sol-Gel
Figure 4A represents the standard curve with known
concentrations of antibiotic and their repectives fluorescence
intensity. The regression coefficients (R2) was 0.9918. The
antibiotic release shows a lineal release over time both from A25
and from A50 (Figure 4B), and maximum release values were
obtained at 48 h for both sol-gels. The moxifloxacin release rate
from A50 (120 ng/h) was significantly higher than the rate from
A25 (60.6 ng/h) (p-value< 0.0001 for t-Student test).
Microbiological Studies
Figures 5A–C shows plots of the bacteria concentration per area
unit that are attached to the surface by means of colony forming
units (CFU). CFU per square centimetre significantly decreased
only on A50 for the three strains used (p-value < 0.05). Plots of
FIGURE 7 | Percentage of biofilm growth respect to the control of S. epidermidis ATCC 35984 (A), S. aureus 15981 (B), and E. coli ATCC 25922 (C) on different
types of coatings: P2, A25 and A50. ∗p-value < 0.05, ∗∗p-value < 0.01, ∗∗∗p-value < 0.001 for Wilcoxon test between biofilm growth on the control and on coatings
loaded with MOX. ###p-value < 0.001 for Wilcoxon test between biofilm growth on A25 and A50.
FIGURE 8 | Cytotoxicity (A) and cell proliferation (B) of MC3T3-E1 cells when growing in presence of each coating. Control was considered in the presence of any
coating. ∗p-value < 0.05 for Wilcoxon test between cell proliferation on control and on different coatings loaded with MOX.
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Figures 5D–F show that the planktonic bacterial concentration
is proportional to the absorbance of the supernatant measured
at 600 nm. Bacterial absorbance was inversely proportional to
moxifloxacin concentration. The microbiological study revealed
two responses for the biofilm development and for the planktonic
bacterial concentration. The biofilm development response was
all-or-nothing for the staphylococci when their biofilms grow in
presence of P2 or A25 (all) and A50 (nothing) (Figures 5A,B, 6).
E. coli ATCC 25922 biofilm development showed a lower
development which was influenced by the concentration of
antibiotic (Figure 5C). On the contrast, the planktonic bacterial
concentration was gradually and inversely proportional to the
moxifloxacin coating concentration for all the tested strains
(Figures 5D–F).
Coatings containing antibiotic behaved as inhibitors of the
growth of a mature biofilm (Figure 7). The unloaded coating
(P2) did not show an inhibitor behavior in the presence of
staphylococci mature biofilms (Figures 7A,B) (p-value > 0.05)
but showed, however, a slightly inhibitor behavior in the presence
of a mature biofilm E. coli (p-value = 0.0088) (Figure 7C). Though
FIGURE 9 | Results of animal monitoring over time. (A,B) Mean weight, (C,D) limping, and (E,F) piloerection in different non-infected groups (circles), Sa5-infected
group (squares), and Ec30-infected group (triangles) with CP (left column) and CP+A50 (right column).
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A25 and A50 are able to inhibit in a similar way the mature
biofilm growth of S. epidermidis ATCC 35984 and E. coli ATCC
25922, A50 showed the highest inhibitor behavior on the mature
biofilm of S. aureus 15981 compared to A25 (p-value< 0.001).
Cellular Studies
Cytotoxicity was not detected in the presence of the coatings
tested respect to the control used (p-value> 0.05) (Figure 8A).
This explains why P2 stimulates significantly up to 30% the
cell proliferation compared to the other coatings and the control
(Figure 8B). However, cell proliferation was also influenced
by the antibiotic added to the coatings. A50 showed a lower
percentage of cell proliferation than the control, meaning the
high quantity of antibiotic added on A50 acted against cells
although only in the first 48 h.
In vivo Studies
Animal Monitoring
The mean weight over time of the mice is shown by group in
Figures 9A,B. All groups significantly increased their weight over
time (p-value< 0.001) except CP Ec30 (p-value = 0.1196).
Only two of the six behavioral variables evaluated showed
a modification during the study: limping and piloerection
(Figures 9C,D). Limping was significantly more frequent in the
CP Sa5 group than the CP+A50 Sa5 groups (p-value < 0.0001)
and was significantly higher in the CP Ec30 group compared
to the CP+A50 Ec30 group (p-value < 0.0001) (Figure 9C).
Piloerection was observed with significantly greater frequency
in the CP Sa5 group than in the CP+A50 Sa5 groups (p-
value = 0.0004) and increased significantly over time in the
CP+A50 Ec30 group compared to the CP Ec30 group (p-
value = 0.0073) (Figures 9E,F).
Microbiological Study
Both of the clinical bacterial strains used were strong
biofilm former: 12.2 (9.3–15.5)×ODC for Sa5 and 4.3
(4.2–4.8)× ODC for Ec30.
Bacteriuria was only detected in nine of the Ec30-infected
mice: four from the CP Ec30 group and five from the
CP+A50 Ec30 group. The antibiotype of E. coli strains
isolated from urine was identical to that of Ec30 strains
inoculated during surgery.
Of all the femurs studied, seven showed macroscopic
deformation consistent with osteomyelitis (Figure 10): five
animals in the CP Sa5 group and two in the CP Ec30 group.
Deformation was higher in CP Sa5 than in CP Ec30.
Statistically significant differences were observed between the
quantity of bacteria in bone and adnexa (p-value = 0.0027 for CP
and CP Sa5, and p = 0.0027 for CP and CP Ec30) and implants
(p-value = 0.0093 for CP and CP Sa5, and p = 0.0275 for CP and
CP Ec30) between the CP groups (Figures 11A,B).
No differences were observed in the number of bacteria in
bone and adnexa and implants (p-value = 1.0000 for CP+A50
and CP+A50 Sa5, and p = 1.000 for CP+A50 and CP+A50 Ec30)
between the CP+A50 groups (Figures 11C,D).
Microcomputed Tomography
No differences were observed between the BMC and BMD of
non-infected CP and non-infected CP+A50 (p-value = 0.1376
and p = 0.4137, respectively) (Figure 12). The BMD results were
perfectly comparable, since BMC was no different between the
groups compared.
Histology
Hematoxylin-eosin staining showed that mice with CP implant
presented fibrous tissue in the area where implant was present
(arrow) (Figure 13). CP+A50 showed absence of tissue what
correlated with the area occupied by the implant (arrow)
(Figure 13). When bone markers were studied, no many changes
were found among different animals. Both groups showed similar
number of TRAP positive cells (arrow), and immunostaining for
cathepsin K (cysteine protease, osteoclast marker) did not showed
any difference, ALP (alkaline phosphatase) positive cells were
similar in CP and CP+A50, but macrophages (CD68 + cells)
were increased in CP+A50.
FIGURE 10 | Photograph of a femur without (A, right) and with osteomyelitis
(A, left) and their radiographic image (B). The bar represents 0.5 cm.
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FIGURE 11 | Quantity of bacteria in bone and adnexa (left column) and on recovered implant (right column) with CP (A,B) and CP+A50 (C,D). ∗p-value < 0.05,
∗∗p-value < 0.01 for Wilcoxon test between non-infected group and infected groups by S. aureus (Sa5) or E. coli (Ec30).
DISCUSSION
In this study, we report the efficacy of a novel approach of
sol-gel coatings containing moxifloxacin, that was demonstrated
to provide an anti-infective surface to Ti-based materials both
in vitro and in vivo. The active surfaces prevented locally the
biofilm development and treated mature biofilms of different
clinically important bacterial species. Finally, we demonstrated
the in vivo efficacy of moxifloxacin-loaded sol-gel in preventing
PJI caused by Gram-positive S. aureus and Gram-negative E. coli.
The microbiological study revealed that only A50 completely
inhibited the formation of biofilm on the coated surface and was
the best treatment for a mature biofilm of the three bacterial
species. Hence, A50 was the most appropriate coating to use in
the in vivo model and would be the best prophylactic treatment
in the clinical practise. The moxifloxacin release rate of A50 was
almost two-fold higher than A25 and showed a lineal trend over
time as other antibiotics (e.g., vancomycin) loaded in sol-gels
made of tetraethyl orthosilicate (Radin and Ducheyne, 2007).
Commonly reported symptoms of PJI include pain, joint
swelling or effusion, erythema or warmth around the joint,
fever, drainage, or the presence of a sinus tract communicating
with the arthroplasty (Tande and Patel, 2014). The joint pain
in our in vivo model was monitored by observing limping, and
generalized malaise was monitored by observing evidence of
piloerection often associated with infection (Campos et al., 2016).
Infected animals with A50-coated implants showed significantly
less limping and piloerection over time than infected animals
with non-coated implants, with the exception of piloerection
in E. coli-infected animals with coated implants (Figure 9). In
these cases of E. coli-infected animals with coated implants,
piloerection was higher in those animals with coated implant
compared to animals with non-coated implants; this may be
due to the bacteriuria observed in these animals. We cannot
completely explain this apparently symptomatic bacteriuria,
though it may be caused by bacterial concentration in the
bladder due to transient bacteraemia (Wang et al., 2017) during
surgery as well as the motility of E. coli (Kaya and Koser,
2012), which allows the bacteria to migrate and colonize a new
niche with lower hostility than the interior of the bone when
it contains an antibiotic-coated implant. The microbiological
results from the in vivo study revealed that moxifloxacin-loaded
sol-gel showed an all-or-nothing response when used to coat the
implant and S. aureus or E. coli infection is induced (Figure 11)
as expected. The femoral deformation observed in S. aureus-
infected groups with non-coated implants is consistent with
the ability of S. aureus to internalize in osteoblasts (Cremet
et al., 2015) and cause deforming osteomyelitis in chronic bone
infections (de Mesy Bentley et al., 2017) (Figure 10). In the case
of E. coli, the bone deformation observed in infected groups
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FIGURE 12 | Bone mineral content (BMC) (a) and bone mineral density (BMD) (b) and their three-dimensional reconstructions of a representative sample of the CP
group (c) and CP+A50 group (d).
FIGURE 13 | Immunohistochemistry for markers of different bone cells. Long bones were processed and immunohistologic staining carried out. Shown are
representative images stained for haematoxilin-eosin (H&E), tartrate-resistant acid phosphatase (TRAP) staining, cathepsin K (cath. K), alkaline phosphatase (ALP)
and macrophages (CD68). H&E images were taken at 4× magnification. All immunostaining images were taken at 10× magnification.
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with non-coated implants may be due to osteoblastic cytotoxicity
(Cremet et al., 2015).
The non-cytotoxicity of these coatings was validated and the
cellular proliferation was slightly favored in presence of P2 and
A25. The addition of tris(trimethylsilyl) phosphite to the sol-
gel formulation created localized areas with higher phosphorus
content that is released in form of phosphate when sol-gel
is degraded over time. This inorganic phosphorus compound
significantly stimulates the growth and osteogenic differentiation
of the bone cells (Liu et al., 2009). This cell proliferation increase
was absent in presence of A50, this may be due to that the
proliferative effect exerted by the phosphate released from sol-
gel degradation would be counteracted by the high moxifloxacin
concentration, an fluoroquinolone antibiotic which has been
frequently associated with a wide spectrum of musculoskeletal
complications that involve not only tendon but also cartilage,
bone, and muscle (Hall et al., 2011; Jacobs et al., 2014). Due
to the degradation of sol-gel would take place after 48–72 h of
surgery, this potential local cytotoxicity would be a assumable
and transient complication by taking into account the beneficit
of prophylaxis. Moreover, moxifloxacin-loaded coating showed
a non-harmful effect on bone mineralization according to the
microcomputed tomographic images (Figure 12) and no changes
in bone markers were found among groups (Figure 13), what
correlates with micro-CT data. The increased in macrophages
in CP+A50 group might be indicating that the local antibiotic
delivery from sol-gel is recruiting macrophages at site of surgery
what would impede the bacterial proliferation, since it has
been also found previously that a multifunctional nanogel for
targeted vancomycin delivery provides macrophage targeting and
lesion site−activatable drug release properties, which enhances
bacterial growth inhibition in a zebra fish in vivo model
(Xiong et al., 2012).
In recent years, different types of coating have been introduced
for clinical use: natural, peptide, ceramic, and synthetic
coatings (Civantos et al., 2017). Most have been designed with
osteointegration (Civantos et al., 2017; Haimov et al., 2017)
and antibacterial purposes (Zhao et al., 2009; Swartjes et al.,
2015; Kulkarni Aranya et al., 2017). To date, antibacterial,
biodegradable perioperative coatings are designed to be loaded
with gentamicin or vancomycin (Romanò et al., 2015) and
are already on the market. One example is a fast-resorbable,
antibiotic-loadable hydrogel composed of covalently linked
hyaluronan and poly-D,L-lactide, whose efficacy has been proven
in vitro (Drago et al., 2014) and in a multicentre randomized
controlled trial (Malizos et al., 2017). Thus, the moxifloxacin-
loaded sol-gel used in our study is a new, cost-effective alternative
for locally preventing and without significant compromising the
bone mineralization. Nevertheless, moxifloxacin can be replaced
by a broad spectrum of antibiotics according to the clinical
need. The use of this biomaterial and its versatility represent an
important advance in Traumatology and Orthopedics field.
In conclusion, coating loaded with higher concentration of
moxifloxacin (A50) showed excellent bactericidal and broad-
spectrum anti-biofilm response since it showed the highest
inhibitor behavior on the biofilm development (local prevention)
and on mature bacterial biofilm (local treatment).
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